» Articles » PMID: 10329541

Activation of the Interferon-inducible (2'-5') Oligoadenylate Synthetase by the Epstein-Barr Virus RNA, EBER-1

Overview
Journal Virology
Specialty Microbiology
Date 1999 May 18
PMID 10329541
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

The 2'-5' oligoadenylate synthetases and the protein kinase PKR are both interferon-induced, double-stranded RNA-dependent proteins that play important roles in the antiviral effects of the interferons and in cellular growth control. Both enzymes are activated by natural or synthetic dsRNAs and by single-stranded RNAs that possess extensive secondary structure. This report describes the effects of the small Epstein-Barr virus-encoded RNA EBER-1 on the regulation of 2-5(A) synthetase activity. We demonstrate that EBER-1 RNA binds to and activates the human 40-kDa 2-5(A) synthetase in a dose-dependent manner. The efficiency of EBER-1 as an activator of 2-5(A) synthetase is approximately 25% of that of the synthetic double-stranded RNA poly(I)/poly(C), and poly(I)/poly(C) further stimulates enzyme activity even in the presence of a high concentration of EBER-1. Conversely, EBER-1 neither stimulates nor inhibits 2-5(A) synthetase that has been activated by a high concentration of poly(I)/poly(C). Competitive binding assays suggest that the relative affinity of the enzyme for poly(I)/poly(C) is considerably higher than that for EBER-1. Our data indicate that EBER-1, like VAI RNA of adenovirus, TAR RNA of HIV-1, and Rex-RE RNA of HTLV-1, is able to activate the 2-5(A) synthetases. The significance of why several viruses may activate the 2-5(A) synthetase/RNase L-mediated RNA degradation pathway is discussed.

Citing Articles

RNase L limits host and viral protein synthesis via inhibition of mRNA export.

Burke J, Gilchrist A, Sawyer S, Parker R Sci Adv. 2021; 7(23).

PMID: 34088676 PMC: 8177694. DOI: 10.1126/sciadv.abh2479.


RNA regulation of the antiviral protein 2'-5'-oligoadenylate synthetase.

Schwartz S, Conn G Wiley Interdiscip Rev RNA. 2019; 10(4):e1534.

PMID: 30989826 PMC: 6585406. DOI: 10.1002/wrna.1534.


Epstein-Barr virus latency: current and future perspectives.

Kempkes B, Robertson E Curr Opin Virol. 2015; 14:138-44.

PMID: 26453799 PMC: 5868753. DOI: 10.1016/j.coviro.2015.09.007.


A novel RNA molecular signature for activation of 2'-5' oligoadenylate synthetase-1.

Vachon V, Calderon B, Conn G Nucleic Acids Res. 2014; 43(1):544-52.

PMID: 25477390 PMC: 4288181. DOI: 10.1093/nar/gku1289.


Learning from the messengers: innate sensing of viruses and cytokine regulation of immunity - clues for treatments and vaccines.

Melchjorsen J Viruses. 2013; 5(2):470-527.

PMID: 23435233 PMC: 3640511. DOI: 10.3390/v5020470.